Previous Article | Next Article ![]()
Molecular and Cellular Biology, February 2003, p. 1358-1367, Vol. 23, No. 4
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.4.1358-1367.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Jung Mo Kim,1,2,3 Lark Kyun Kim,1,2 Se Nyun Kim,1,2 Jeongsil Kim-Ha,4 Jung Hoe Kim,3 and Young-Joon Kim1*
Department of Biochemistry, National Creative Research Initiative Center for Genome Regulation, Yonsei University,1 Digital Genomics, Inc., Seoul 120-749,2 Department of Molecular Biology, Sejong University, Seoul 143-747,4 Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejon 305-701, Korea3
Received 5 June 2002/ Returned for modification 17 July 2002/ Accepted 7 October 2002
The Mediator complex is the major multiprotein transcriptional coactivator complex in Drosophila melanogaster. Mediator components interact with diverse sets of transcriptional activator proteins to elicit the sophisticated regulation of gene expression. The distinct phenotypes associated with certain mutations in some of the Mediator genes and the specific in vitro interactions of Mediator gene products with transcriptional activator proteins suggest the presence of activator-specific binding subunits within the Mediator complex. However, the physiological relevance of these selective in vitro interactions has not been addressed. Therefore, we analyzed dTRAP80, one of the putative activator-binding subunits of the Mediator, for specificity of binding to a number of natural transcriptional activators from Drosophila. Among the group of activator proteins that requires the Mediator complex for transcriptional activation, only a subset of these proteins interacted with dTRAP80 in vitro and only these dTRAP80-interacting activators were defective for activation under dTRAP80-deficient in vivo conditions. In particular, activation of Drosophila antimicrobial peptide drosomycin gene expression by the NF-
B-like transcription factor Dif during induction of the Toll signaling pathway was dependent on the dTRAP80 module. These results, and the indirect support from the dTRAP80 artificial recruitment assay, indicate that dTRAP80 serves as a genuine activator-binding target responsible for a distinct group of activators.
Present address: Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA 92093-0636.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|